GRAY News and Press, Graybug Vision Inc.

- CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC” - Cash and cash equivalents of approximately $34 million as of merger close expected to support operations into the second half of 2024 - Phase 2b results ...

REDWOOD CITY, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY) (Graybug) today announced that it has changed its name to CalciMedica, Inc. (the Company), which will become effective at 4:02 pm ET. In connection with the name change, the Company has changed its tradin...

Toronto, Ontario--(Newsfile Corp. - March 2, 2023) - Graycliff Exploration Limited  (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) (the " Company " or " Graycliff ") is pleased to announce that it has acquired the Lunge Project ("Lunge") located on the prolific Canadian Shield in the Sudbury Basin...

Toronto, Ontario--(Newsfile Corp. - February 22, 2023) - Graycliff Exploration Limited  (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) (the " Company " or " Graycliff ") today announces that it has completed the Phase 4 drilling program at its 100%-owned Shakespeare Gold Project located in th...

NEW YORK, NY / ACCESSWIRE / December 21, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerojet Rocketdyne Holdings, Inc. (N...

NEW YORK, NY / ACCESSWIRE / December 7, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Graybug Vision, Inc. (NASDAQ:GRAY)'s ...

– Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases – Combined company is expected to be funded with cash ...

Graybug Vision press release ( NASDAQ: GRAY ): Q3 GAAP EPS of -$0.46 misses by $0.08 . As of September 30, 2022, the Company’s cash, cash equivalents, and short-term investments totaled $43.6 million. Subject to the outcome of the previously announced strategi...

REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY) (“Graybug” or the “Company”), a clinical-stage biopharmaceutical company focused historically on developing transformative medicines for ocular diseases, today reported fi...

Graybug Vision press release ( NASDAQ: GRAY ): Q2 GAAP EPS of -$0.38 beats by $0.02 . As of June 30, 2022, the company’s cash, cash equivalents, and short-term investments totaled $50.7 million. Management believes Graybug’s current cash and investments a...